XGN
Exagen
$4.40
−$0.28 (−5.98%)Jul 27, 2026
Key metrics
The numbers that frame XGN today
- Market cap
- $106.30M
- P/E (TTM)
- -5.3
- EV / FCF
- -7.9
- Gross margin
- 58.3%
- EV / Sales
- 1.6
- ROIC
- -35.3%
- Div yield
- 0%
- Debt / equity
- 1.9
- 52wk Low
- $2.60
- 52wk High
- $12.23
Growth
Revenue and earnings trend for XGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XGN
Is Exagen a good buy?
No. Exagen has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Exagen is selling at a very high price.
What is the market capitalization of XGN?
Exagen's market capitalization is $106.30M.
What is the P/E ratio for XGN stock?
Exagen's current P/E ratio is -5.3.
What is the 52-week high for XGN stock?
The 52-week high for Exagen is $12.23. The current close of $4.40 is 64% below that high.
What is the 52-week low for XGN stock?
The 52-week low for Exagen is $2.60. The current close of $4.40 is 69.2% above that low.
Does XGN stock pay dividends?
Exagen does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XGN?
Exagen's Debt / Equity ratio is 1.88.